All news articles for April 2019

(Image: Getty/Seb_Ra)

BMS-Celgene mega-merger receives shareholder nod

By Ben Hargreaves

The $74bn deal appeared to be fraying around edges, as certain shareholders voiced dissent, but a vote saw the deal pass with support from more than 75% of investors.

(Image: Getty/Anghi)

GSK gets first approval for two-drug HIV treatment

By Ben Hargreaves

GSK’s Dovato is approved by the US FDA for the treatment of individuals with HIV with no previous antiretroviral therapy, in a first for a two-drug, fixed-dose, complete regimen.